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Abstract
Background: Foot and mouth disease is an economically important disease of cloven-hoofed animals including cattle,
sheep and pigs. It is caused by a picornavirus, foot-and-mouth disease virus (FMDV), which has a positive sense RNA
genome which, when introduced into cells, can initiate virus replication.
Principal Findings: A system has been developed to rescue infectious FMDV from RNA preparations generated from clinical
samples obtained under experimental conditions and then applied to samples collected in the ‘‘field’’. Clinical samples from
suspect cases of foot-and-mouth disease (FMD) were obtained from within Pakistan and Afghanistan. The samples were
treated to preserve the RNA and then transported to National Veterinary Institute, Lindholm, Denmark. Following RNA
extraction, FMDV RNA was quantified by real-time RT-PCR and samples containing significant levels of FMDV RNA were
introduced into susceptible cells using electroporation. Progeny viruses were amplified in primary bovine thyroid cells and
characterized using antigen ELISA and also by RT-PCR plus sequencing. FMD viruses of three different serotypes and
multiple lineages have been successfully rescued from the RNA samples. Two of the rescued viruses (of serotype O and Asia
1) were inoculated into bull calves under high containment conditions. Acute clinical disease was observed in each case
which spread rapidly from the inoculated calves to in-contact animals. Thus the rescued viruses were highly pathogenic. The
availability of the rescued viruses enabled serotyping by antigen ELISA and facilitated genome sequencing.
Conclusions: The procedure described here should improve the characterization of FMDVs circulating in countries where
the disease is endemic and thus enhance disease control globally.
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Introduction
Foot-and-mouth disease (FMD) is one of the most economically
important diseases of farm animals [1,2]. The disease is
widespread across the world especially in Africa and Asia. In
addition, there are occasional incursions into countries which are
normally free, e.g. within Japan (in 2000 and 2010) and the United
Kingdom in 2001 (which resulted in spread to Ireland, France and
the Netherlands) causing very high economic losses. The disease is
caused by infection with foot-and-mouth disease virus (FMDV),
the prototypic Aphthovirus within the family Picornaviridae. FMDV
particles comprise a single copy of the positive-sense RNA genome
(ca. 8300 nt in length) within a near spherical protein capsid of ca.
28 nm which contains 60 copies of 4 different structural proteins,
1A (VP4), 1B (VP2), 1C (VP3) and 1D (VP1) (for review, see [3]).
The viral RNA is sufficient to initiate replication when introduced
into the cytoplasm of cells (e.g., see [4,5]), without any requirement
for viral proteins Thus the capsid serves to protect the RNA when
the virus is outside of cells and to facilitate delivery of the genome
into the cytoplasm of cells in which replication occurs [3].
FMD can be controlled successfully by vaccination. How-
ever, there are seven distinct serotypes (O, A, C, Asia 1, SAT
1, SAT 2 and SAT 3) and many subtypes have also been
described [2,6]. Vaccination against one serotype produces
little or no protection against other serotypes. Thus, it is
essential that the correct vaccine is chosen for the control of
each outbreak.
In countries lacking the infrastructure to identify rapidly the
serotype of FMDV in samples, these can be transported to
reference laboratories, e.g. the World Reference Laboratory at
Pirbright, U.K., for characterization. However, this currently
involves the transportation of samples containing infectious
FMDV which represents a significant bio-security hazard and
also incurs significant costs. Moreover, the virus samples have to
be collected and stored under appropriate conditions, until
submission, to allow virus to be isolated successfully in the
receiving laboratories. In practice, this can be difficult when
ambient temperatures are high and distances from points of
collection to national laboratories are large and the infrastructure
is poor. It is therefore desirable to have a system where samples
from suspect clinical cases of FMD can be treated at the point of
collection to inactivate the virus but preserve the RNA in a
manner which allows the subsequent recovery of infectious virus
within a contained laboratory environment.
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e14621
The availability of commercial reagents which preserve the viral
RNA, in conjunction with systems for the efficient rescue of
picornaviruses from RNA (e.g. as used in [5]), has permitted the
development of a protocol for the recovery of infectious FMDV
from chemically treated virus samples. Indeed, a method for
rescue of FMDV and classical swine fever virus from viral RNA
stored in Trizol has been reported previously [7]. Related
methodology has now been used to show that FMD viruses,
which retain their pathogenicity, can be obtained from preserved
virus preparations that were collected as clinical samples in one
country and then transported to the National Veterinary Institute
(DTU Vet), Lindholm, Denmark. This serves as a ‘‘proof of
principle’’ for a system of efficient collection and preservation of
FMDV samples in the field prior to comprehensive laboratory
analysis of the rescued viruses.
Materials and Methods
Ethics statement
All animal work was approved and conducted according to the
requirements of the Danish Animal Experiments Inspectorate
(Licence no. 2008/561-1541).
Preparation and quantification of FMDV RNA
An aliquot of bovine tongue epithelium suspension, stored at -
70uC, (generated by Carolina Stenfeldt and Søren Alexandersen at
DTU Vet, Lindholm) from a bull calf infected with FMDV
(serotype O-UKG 34/2001) was used as a source of FMDV RNA
obtained from clinical material. Nucleic acid was isolated using
both robotic (MagNA Pure LC Total Nucleic Acid Isolation Kit)
and manual (QIAampHRNA Blood Mini Kit) protocols as
described by the manufacturers and the RNA samples were
eluted in 50 or 60 ml of water respectively.
FMDV RNA, within these RNA preparations, was quantified
using two different real time RT-PCR assays, that target either the
59 untranslated region or the 3D coding region, as described
previously [8,9,10]. On the basis of these initial assays, samples
containing a level of FMDV RNA which were expected to yield, in
this standard diagnostic assay, Ct values of 15, 20, 25 and 30
respectively were prepared and re-assayed. It should be noted that
each increase in Ct value of 5 represents a 25 ( = 32)-fold decrease
in the level of FMDV RNA.
Clinical samples (over 1500) were collected in Pakistan and
Afghanistan as part of an FAO Regional Project (GTFS/INT/
907/ITA). Mouth swab samples were placed directly into RLT
buffer (Qiagen) while epithelium tissue samples, from clinically
diseased animals, were initially collected in phosphate buffered
saline (PBS) and then transferred to RNAlater (Ambion) in a
laboratory prior to transportation to DTU Vet, Lindholm. From
these preserved samples, RNA was isolated and the level of FMDV
RNA was quantified by real time RT-PCR as above. Samples
prepared from epithelium samples typically had the highest
amounts of FMDV RNA.
Rescue of infectious FMDV from FMDV RNA
Trypsinized BHK cells (800 ml of 26106 cells/ml) in PBS were
mixed with 7 ml of RNA in a cuvette (0.4 cm) and subjected to a
single, square wave, electrical pulse (25 ms) of 240V using a
BioRad Gene Pulser Xcell electroporation system. The treated
cells were added to a monolayer of primary bovine thyroid (BTY)
cells (in a 6 well plate) and incubated at 37uC for 2 days prior to
harvesting by freezing at270uC. An aliquot (200 ml) of the harvest
was added to fresh BTY cells and incubated for a further 1–2 days
prior to harvesting as above. Cells were examined on a daily basis
to assess the generation of CPE. Stocks of the rescued viruses were
grown in BTY cells in 25 cm2 flasks and were titrated as described
below.
Characterization of rescued FMD viruses
The titre of the rescued virus samples was determined from 5
replicate dilution series in BTY cells (96 well plates), CPE was
scored after both 1 and 2 days and the titre determined at 3 days
post infection as TCID50 [11].
A previously described FMDV antigen ELISA [12,13] was used
to identify the serotype of the rescued FMDV and to demonstrate
the presence of the expected serotype of FMDV in vesicular fluid
obtained from experimentally infected animals (see below).
Samples of the virus harvest were also used to generate RNA
samples as described above and used in RT-PCR assays using
appropriate primer sets to obtain overlapping cDNA fragments
corresponding either to selected regions of the genome or, in some
cases, to the near complete genome (lacking the extreme 59
untranslated region on the 59 side of the poly(C) tract). DNA
sequences of the amplicons were generated by Agowa (Germany).
Sequence assembly was achieved using SeqMan Pro, sequence
comparisons were performed using BLAST (www.ncbi.nlm.nih.
gov) and the comparison of VP1 amino acid sequences was
assessed using MEGA version 4 [14].
Assessment of rescued virus pathogenicity in cattle
Two similar experiments were performed to determine the
pathogenicity of two distinct rescued FMD viruses of different
serotypes (O and Asia 1). In each case, two male calves (ca. 200 kg)
were inoculated into the tongue, at two sites, with ca.107 TCID50
(in total) of FMDV. Each inoculated animal was kept in contact
with two other similar calves in pens within high containment
animal accommodation and were monitored on a daily basis for
signs of clinical disease (including elevated rectal temperature,
drooling and appearance of vesicles in the mouth and on the feet)
for a period of 10 days (unless euthanized prior to this time).
Serum and mouth swab samples were collected before and daily
after inoculation of the animals until euthanasia. RNA was then
extracted from these samples and assayed for the presence of
FMDV RNA by real time RT-PCR as above. The level of RNA
detected in serum samples was converted to genomes per/ml by
reference to a standard curve of reference RNA samples assayed in
parallel (n.b. the level of genomes/ml will greatly exceed the level
of virus detected by infectivity assays, commonly, for picornavi-
ruses, a particle to pfu ratio of about 100 can be expected). The
serum samples were also screened for the presence of anti-FMDV
antibodies (using a 1:10 dilution of serum) using serotype specific
antibody ELISA systems (for O and Asia 1 as appropriate) and
positive samples were then titrated to quantify the antibody
content [15,16].
Results
Rescue of virus from RNA isolated from FMDV-infected
bovine tongue epithelium
To optimize the procedure for the rescue of infectious FMDV
from RNA preparations derived from clinical samples, initially
RNA was isolated from bovine tongue epithelium suspension
which was generated from cattle infected with serotype O FMDV
(O-UKG 34/2001). The RNA was prepared both manually and
by robot, then the FMDV RNA was quantified in each
preparation using a standard diagnostic real-time RT-PCR assay
[8]. The Ct values obtained for neat and a 10-fold dilution series of
these samples are shown in Figure 1, panel A. As expected, a high
Rescue of Pathogenic FMDV
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level of FMDV RNA was present in both of these RNA
preparations. A further dilution series was then made from the
undiluted RNA preparation (QIAamp method) to generate
samples with Ct values of 15, 20, 25 and 30 and the expected
level of FMDV RNA was confirmed using the same assay (data not
shown). Following optimisation of parameters for the introduction
of FMDV RNA into BHK cells, a standard protocol was adopted
as described in Material and Methods. Using this procedure,
suspensions of BHK cells were electroporated in the presence of
aliquots of the FMDV O UKG 34/2001 RNA dilution series (with
Ct values of 20, 25 and 30). These cells were then added to a
monolayer of primary bovine thyroid cells (BTY) and the
harvested material was then passaged again on fresh BTY cells.
On each day, the cells were examined for the appearance of CPE
(see Table 1).
It should be noted that on day 1 following electroporation, it is
difficult to score low levels of CPE due to the large number of dead
and floating cells, however, when high levels of viral RNA were
present in the samples, then CPE could be observed on day 2.
Furthermore, even when the lowest level of RNA was used, the
generation of CPE in the second passage was evident on day 2.
To determine that the CPE resulted from the rescue of virus
from the electroporated FMDV RNA, a serotype specific antigen
ELISA for FMDV was employed using the material harvested
after the 2nd passage. This assay has the feature that it has an
absolute requirement for virus replication in order to generate the
virus protein which is detected since only viral RNA was applied to
the cells. The results are shown in Figure 1 (panel B). As expected
from the source of the RNA (FMDV O UKG/34/2001) a strong
signal was obtained for serotype O FMDV but no reactivity in a
serotype A-specific assay was observed. Consistent with the
generation of CPE that was obtained, a positive signal was
observed in the serotype O specific antigen ELISA for each of
these different RNA preparations.
Rescue of FMDV from field samples preserved in
RNAlater
Clinical samples (over 1500) were collected from cattle and
buffalo from within Pakistan and Afghanistan. These materials
included samples of bovine tongue epithelium from clinically
diseased animals which were collected in PBS, transported back to
the National Veterinary Laboratory in Pakistan or Afghanistan
and then transferred to RNAlater to preserve the RNA and
inactivate the virus. Following transportation to DTU Vet,
Lindholm, total RNA was extracted from these samples and the
presence of FMDV RNA was established and quantified using real
time RT-PCR assays. With samples shown to contain FMDV
RNA, conventional RT-PCR assays were used to amplify cDNA
corresponding to the entire VP1 coding sequence and the
amplicons (ca. 900 bp) were sequenced in order to identify the
serotype of FMDV present within the clinical samples.
In an initial experiment, a collection of nine different RNA
samples prepared from clinical samples obtained in Afghanistan
and Pakistan and shown to contain high levels of FMDV RNA (by
real-time RT-PCR) were selected to attempt virus rescue. From
comparisons with other FMDV sequences (using BLAST) with the
VP1 coding sequences of amplicons generated in conventional
PCRs, it was known that these clinical samples contained FMDV
RNA derived from either serotype A or Asia 1 viruses (see Table 2).
Following introduction of these RNA samples into cells by
electroporation and passaging in BTY cells, extensive CPE was
apparent from two separate samples. Both of the RNA samples
(Asia-1/BAM/AFG/L1/2009 and Asia-1/BAM/AFG/L2/2009)
which were rescued back to virus (to produce the virus samples
Asia-1/BAM/AFG/L590/2009 and Asia-1/BAM/AFG/L591/
2009 respectively) had been prepared from bovine tongue
epithelium collected in Afghanistan. In these RNA preparations,
high levels of FMDV RNA were detected (Ct ,20, see Table 2).
Using the RNA prepared from the rescued viruses, sequencing of
Figure 1. Rescue of serotype O FMDV following electropora-
tion of BHK cells with RNA isolated from tongue epithelium
suspension derived from a bovine infected with O UKG/35/
2001 FMDV. Panel A. Quantitation of FMDV RNA by real-time RT-PCR
following isolation by manual (Qiagen) or robotic (Roche MagNa Pure)
systems. Panel B. RNA samples containing the indicated levels of FMDV
RNA (as measured by real-time RT-PCR) were introduced into BHK cells
by electroporation and rescued virus was propagated in BTY cells as
described in materials and methods. The virus harvest (2nd passage) was
diluted (1:50) and assayed in separate FMDV antigen ELISAs specific for
serotype O (black bars) and A (open bars).
doi:10.1371/journal.pone.0014621.g001
Table 1. Rescue of infectious FMDV from FMDV RNA.
FMDV RNA
1st passage
(BHK/BTY cells)
2nd passage
(BTY cells)
Ct value Day 1 Day 2 Day 1 Day 2
Ct 20 ? ++ ++ +++
Ct 25 ? neg neg +++
Ct 30 ? neg neg ++
Different levels of FMDV RNA (expressed as the Ct value from the standard
assay) were introduced into BHK cells by electroporation and added to
monolayers of BTY cells. The cells were examined each day for virus production
(as indicated by generation of CPE, ++ indicates partial or +++ complete cell
lysis) For the second passage, 200 ml of virus harvest was added to a fresh
monolayer of BTY cells. Neg indicates no CPE while the (?) indicates uncertainty
due to the presence of many floating cells generated by the electroporation.
doi:10.1371/journal.pone.0014621.t001
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amplicons showed that the VP1 coding sequences were identical,
in each case, to that generated from the input RNA. Furthermore,
in an antigen ELISA, the rescued viruses were both serotyped as
Asia 1, as expected from the sequence analysis, with no significant
signal for serotypes O, A or C (Figure 2).
Subsequently, four other viruses have been rescued from
epithelium samples collected in Pakistan and Afghanistan, each
successful rescue was from RNA samples which had a Ct value
of ,20 (see Table 3). One of these virus samples was identified
from sequencing of the VP1 coding region as containing
serotype O FMDV (this rescued virus was designated O/ISL/
PAK/L1573/2009 and was derived from RNA sample O/ISL/
PAK/L1413/2009) while three others were serotype A; each of
the latter belonged to the A IRN05 lineage but were distinct
from the currently known sub-lineages, A IRN05AFG-07 and A
IRN05BAR-08 (showing only 93 and 92% nucleotide sequence
identity, respectively, within the VP1 coding region). As with the
Asia 1 viruses, VP1 coding sequences determined from the
initial RNA preparations and from the rescued serotype O and
A viruses were identical except for a single nucleotide
substitution. Thus, in total, some 850 bp have been sequenced
from amplicons, including the complete VP1 coding sequence
derived from the six RNA samples generated both before and
after virus rescue, and only a single nucleotide discrepancy (out
of over 10,000 nt examined) in one of the six rescued viruses has
been detected.
Table 2. Rescue of infectious FMDV from RNA samples isolated from bovine tongue epithelium from suspected cases of FMD in
Afghanistan (AFG) and Pakistan (PAK).
Samples Real time RT-PCR Virus isolation (CPE)
1st passage 2nd passage
59-UTR (Ct) 3D (Ct) BHK BTY
Asia-1/BAM/AFG/L1/2009 19.4 16.1 Neg +++
Asia-1/BAM/AFG/L2/2009 19.3 16.4 Neg +++
Asia-1/BAM/AFG/L3/2009 21.8 19.9 Neg Neg
A/SIN/PAK/L4/2008 26.6 20.2 Neg Neg
Asia-1/SIN/PAK/L5/2008 21.4 19.3 Neg Neg
A/SIN/PAK/L6/2008 24.2 18.2 Neg Neg
A/SIN/PAK/L7/2008 27.6 19.3 Neg Neg
Asia-1/SIN/PAK/L8/2008 21.8 19.8 Neg Neg
A/SIN/PAK/L9/2008 29.0 21.1 Neg Neg
O UKG/34/2001 (pos control) 20 Neg +++
Neg contol - - Neg Neg
The presence of FMDV RNA was determined using real time RT-PCR assays which detect the 59 UTR or the 3D coding sequence. The serotype of the virus from which the
RNA was obtained was determined from VP1 coding sequence determination and comparison with other FMDV strains using BLAST. The success of virus rescue was
determined by the presence of CPE (indicated by +++).
doi:10.1371/journal.pone.0014621.t002
Figure 2. The rescued virus harvests Asia-1/BAM/AFG/L590/2009 (black bars, derived from RNA sample Asia-1/BAM/AFG/L1/2009)
and Asia-1/BAM/AFG/L591/2009 (open bars, derived from RNA sample Asia-1/BAM/AFG/L2/2009) were diluted (1:25) and analysed,
in parallel, in separate FMDV antigen ELISAs specific for serotypes O, A, C and Asia 1 as indicated.
doi:10.1371/journal.pone.0014621.g002
Rescue of Pathogenic FMDV
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Thus from 16 clinical samples, containing high levels of FMDV
RNA (Ct value of ,20) that were tested in the virus rescue system,
some 6 different viruses have been rescued which are represen-
tatives of 3 different serotypes (O, A and Asia 1).
Genome sequence analysis using rescued viruses
The availability of the rescued viruses greatly facilitated the
process of generating near complete genome sequences. To obtain
these sequences (ca. 8000 nt) for the rescued serotype O (O/ISL/
Table 3. Rescue of multiple strains of FMDV from RNA samples isolated from bovine tongue epithelium from suspected cases of
FMD in Afghanistan and Pakistan.
Virus sample and serotype
(from VP1 sequencing)
Real time RT-PCR
(Ct)(59UTR)
Virus
Rescued
Serotype O
Ag ELISA (OD)
Serotype A
Ag ELISA
(OD)
A/KUN/AFG/L629/2009 16.6 -
Asia-1/BAM/AFG/L640/2009 16.9 -
Asia-1/BAM/AFG/L641/2009 16.4 -
Asia-1/BAM/AFG/L643/2009 15.4 -
O/SIN/PAK/L693/2009 21.8 -
O/PUN/PAK/L1347/2008 20.2 -
A/PUN/PAK/1354/2009 13.8 -
A/PUN/PAK/1355/2009 21.0 -
O/PUN/PAK/L1358/2008 17.9 -
A/ISL/PAK/L1411/2009 19.2 -
O/ISL/PAK/L1413/2009 19.0 + 1.56 0.09
A/BAL/AFG/L1430/2009 18.7 -
A/SAR/AFG/L1435/2009 18.2 -
A/HIR/AFG/L1483/2009 13.7 + 0.15 1.53
A/HIR/AFG/L1485/2009 14.4 + 0.03 *0.31
A/KAP/AFG/L1491/2009 15.1 -
A/KUN/AFG/L1495/2009 16.3 + 0.21 1.75
The presence of FMDV RNA was determined using qRT-PCR assays, the serotype was determined from sequencing of amplicons including the VP1 coding sequence and
then the RNA was introduced into BHK cells by electroporation as described in Material and Methods. When virus was successfully rescued, as determined by the
generation of CPE (indicated by (+)), the harvested viruses (diluted 1:25) were assayed for the presence of FMDV antigen using serotype specific ELISAs.
*Incomplete CPE was apparent in this sample.
doi:10.1371/journal.pone.0014621.t003
Figure 3. Diversity within VP1 amino acid sequences from PanAsia serotype O FMDVs including recent strains in circulation in
Pakistan and Afghanistan. Amino acid sequences for the G-H loop portions of the VP1 capsid protein (which is important for FMDV antigenicity
and receptor binding) were derived from reference PanAsia I and PanAsia II strains available in GenBank (accession numbers are indicated) and
aligned with the derived VP1 sequences from current serotype O strains circulating in Pakistan and Afghanistan obtained in this study. The positions
of shared amino acid substitutions are indicated by arrows.
doi:10.1371/journal.pone.0014621.g003
Rescue of Pathogenic FMDV
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PAK/L1573/2009) and Asia 1 (Asia-1/BAM/AFG/L590/2009)
viruses, some 15 separate RT-PCR products were generated to
provide overlapping cDNA fragments corresponding to all the
genome sequence on the 39 side of the poly(C) tract. These
amplicons were sequenced in both directions and the sequences
were then assembled and shown to include a single large open
reading frame as expected. These sequences have been submitted
to Genbank (accession numbers HQ113232 and HQ113233 for
these type O and Asia 1 viruses respectively).
The Asia-1/BAM/AFG/L590/2009 virus is most closely
related (96–98% nt identity in VP1 coding sequences) to viruses
causing disease outbreaks in 2003 in Tajikistan, Uzbekistan and
Afghanistan, in 2004 in Kyrgyzstan and Pakistan and in 2005 in
Hong Kong and this represents a reappearance of this serotype in
this region. The serotype O virus (O/ISD/PAK/L1573/2009) is
related to the Pan Asia II strains that have circulated widely in
recent years. However the VP1 coding sequence is only about
94% identical to the representative PanAsia II viruses [e.g. O/
Pak4/2006 (accession no. EF494501.1) and O/Pak6/2006
(accession no. EF494500.1)] and thus represents a new sub-
lineage. This has been tentatively assigned as a PanAsia III lineage
but this will probably be dependent on the survival and spread of
this strain. Analysis of the near complete genome sequences of this
virus and other more typical PanAsia II strains (which are still in
circulation in Pakistan (e.g. O/NWF/PAK/L1417/2009)) indi-
cated a sequence identity of about 95% across the entire genome.
However, it is interesting to note that the deduced amino acid
sequences of the VP1 proteins from the O/ISL/PAK/L1573/
2009 virus and some other samples collected in Pakistan during
2009 differ from the Pan Asia II serotype O viruses which are still
currently circulating there and include changes flanking the
receptor binding motif (RGDLXXL) within residues 140–160 (G-
H loop) which is an important antigenic site (see Figure 3). A fuller
analysis of the different serotype O viruses currently circulating in
Pakistan will be reported separately (Jamal et al., submitted for
publication).
Analysis of rescued FMDV pathogenicity in cattle
To test the pathogenicity of the rescued viruses, two
experiments were performed using the serotype Asia 1 and
serotype O viruses. In each case, two bull calves were inoculated
into the tongue and each of these was then kept with two in-
contact calves and all six animals were closely monitored over a
period of 10 days during which time serum and mouth swab
Figure 4. Inoculation and infection of bovine calves by the rescued FMDV Asia-1/BAM/AFG/L590/2009. Calves 1C1 and 1C5 were
inoculated into the tongue with the rescued virus (107 TCID50) and housed in contact with 4 control animals (in 2 separate pens containing calves
1C1-1C3 and 1C4-1C6 respectively). The calves were monitored for clinical signs (including temperature, note these are mean values for the animals
within each group for clarity, panel A) and the presence of lesions in the mouth and on the feet). Oral fluid was collected as swab samples, in addition
blood samples were obtained and the serum was assayed for the presence of anti-Asia 1 FMDV antibodies (panel B) in a screening assay using a
single dilution of serum (1:10). Positive samples (blocking.35%, which is the diagnostic cut off point and indicated by a horizontal line) were titrated
(see Table 4). The level of FMDV RNA in serum samples was also determined by real-time PCR and expressed as the number of RNA copies/ml serum
(panel C) and the presence of FMDV RNA in mouth swab samples (mean of the values determined for each group) is indicated in panel D. Note, due
to differences in the amount of sample collected on a swab the level of FMDV RNA has not been converted to the number of genome copies but
expressed in relative terms.
doi:10.1371/journal.pone.0014621.g004
Rescue of Pathogenic FMDV
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samples were collected. The presence of FMDV RNA in these
samples was determined and the generation of anti-FMDV
antibodies within the sera was assayed.
In the experiment using the rescued serotype Asia 1 virus (Asia-
1/BAM/AFG/L590/2009), the two inoculated cattle exhibited an
elevated temperature at 1 dpi and this remained high for another 2
days (Figure 4A). Vesicles appeared in both the interdigital space
of the front feet and the coronary band of the rear feet on day 3 pi.
In addition, vesicles were also observed from day 3 or 4 on both
the upper and lower gingiva and both animals were drooling.
These clinical signs of FMD continued for some days but visible
healing was apparent from day 7 pi. The in-contact animals had a
normal temperature until 3 days after the inoculation of the other
cattle and then a more moderate elevation in temperature was
observed which persisted for about 3 days (Figure 4A). Vesicles on
the front and rear feet of these animals became apparent from day
4. In addition, vesicles were observed from days 4–5 on the tongue
and on both the upper and lower gingiva which were also
accompanied by drooling.
Sera collected from the animals were tested for antibodies
against FMDV in a competition ELISA, initially using a single
dilution of serum (Figure 4B). Both the inoculated cattle (1C1 and
1C5) had seroconverted to FMDV at 4 dpi and two of the four in-
contact animals had clearly seroconverted by day 7 while the
remaining two seroconverted on days 8 and 9. Sera which were
shown to be positive in this assay were also titrated (see Table 4).
The titres of antibodies against FMDV were still fairly low in two
of the in-contact animals (1C4 and 1C6) at the termination of the
experiment on day 10 but in each of the others a high titre (1:160)
was observed. Quantification of the FMDV RNA in the serum
samples (Figure 4C) showed that viræmia occurred at days 1–4 in
the inoculated animals while in the in-contact animals viræmia
occurred between days 2–9 (but only for a period of up to 4 days in
any one animal) and then subsided coincident with the induction
of anti-FMDV antibodies in the serum. FMDV RNA was detected
in mouth swab samples from day 1 in the inoculated animals and
from day 2, initially at a rather lower level, in the in-contact
animals (Figure 4D) and then persisted in both groups of animals,
but at a declining level, for the rest of the experiment (until 10 dpi).
Similarly, in the experiment using the rescued serotype O virus
(O/ISL/PAK/L1573/2009), the two inoculated cattle exhibited a
markedly elevated temperature at 1 dpi which gradually subsided
over the next 3 days (Figure 5A). Vesicles appeared on the upper
gingiva in both animals at 2 dpi and on the feet at 3 dpi. The in-
contact animals had a normal temperature until 3 days after the
challenge cattle were inoculated and then a significant elevation in
temperature was observed which persisted for 3 days. All the
animals developed vesicles in the mouth and on the feet by 4 dpi
and due to the severity of lesions observed (severe damage to the
tongue epithelium plus vesicles on all four feet) in one of the in-
contact animals (2C6) it was euthanized on day 4.
Both the inoculated cattle (2C1 and 2C5) seroconverted to
FMDV at 5 dpi and the three surviving in-contact animals
seroconverted on day 8 (see Figure 5B). Not surprisingly, no
antibody response was detectable in animal 2C6 at the time it was
euthanized. It is apparent from Figure 5B that a rising level of anti-
FMDV antibodies could be detected in the sera prior to their level
reaching the diagnostic cut off point (this was also true in the
experiment with the Asia 1 virus, see Figure 4B). Positive sera were
titrated (see Table 5) and it was found that high levels of anti-
FMDV antibodies were generated in the two inoculated animals
and in one of the in-contact animals but the antibody titres were
still moderate (1:80) in the remaining two in-contact animals (2C2
and 2C3) at the termination of the experiment on day 10.
Quantification of the FMDV RNA in the serum samples
(Figure 5C) showed the peak viræmia occurred at days 1 and 2 in
the inoculated animals and then subsided as the anti-FMDV
antibodies became detectable in the serum from day 3. In the in-
contact animals, the peak viræmia occurred at days 3 to 5 post
inoculation of the other animals and had significantly reduced by
day 7 when anti-FMDV antibodies became detectable in the
serum (Figure 5B). It is interesting to note that the highest level of
viræmia was detected in one of these in-contact animals, calf 2C6,
which was euthanized due to the severity of clinical disease. The
level of FMDV RNA reached 7.4–9.36109 genomes/ml serum on
days 3 and 4 which was about 30-times higher than observed in
any other animal (see Figure 5C); the next highest level was
3.26108 genomes/ml observed in the inoculated calf 2C5 on day
1 post inoculation.
In this experiment, significant levels of FMDV RNA were also
detected in mouth swab samples from day 1 in the inoculated
animals and from day 3 in the in-contact animals which then
gradually declined through to the completion of the experiment
(see Figure 5D). It is apparent that the detection of viral RNA in
the oral swabs was possible for a much longer period of time than
the period of viræmia (see Figure 4 C, D and Figure 5 C, D).
Discussion
In this study we have successfully demonstrated a process of
rescuing infectious FMDV from RNA extracted from preserved
clinical samples and the work confirms and significantly extends
previous studies [7]. In this procedure, clinical samples were
collected from suspected cases of FMD in Pakistan and
Afghanistan and then treated to preserve the FMDV RNA. The
samples were then transported to a high containment laboratory;
viral RNA was isolated and then introduced back into cells, by
electroporation, to rescue infectious FMDV. Importantly, we have
shown that FMD viruses of three different serotypes (O, A and
Asia 1 and also different sub-lineages of these serotypes) can be
Table 4. Titration of anti-FMDV serotype Asia 1 antibodies
induced following infection with rescued serotype Asia 1
FMDV.
Calves
dpi 1C1 1C2 1C3 1C4 1C5 1C6
-4 - - - - - -
1 - - - - - -
2 - - - - - -
3 - - - - - -
4 ,10 - - - - -
5 10 - - - ,10 -
6 N.D. N.D N.D. N.D. N.D. N.D.
7 160 20 ,10 - 80 -
8 160 160 40 ,10 160 -
9 160 160 80 40 160 ,10
10 160 160 160 40 160 20
Values are reciprocals of the highest serum dilutions yielding positive results in
the blocking ELISA on the indicated day post inoculation (dpi). A (-) indicates
samples which were scored negative in the spot test (see Figure 4B) and N.D.
indicates when samples were not collected. Calves 1C1 and 1C5 were
inoculated with the rescued serotype Asia 1 FMDV (Asia-1/BAM/AFG/L590/
2009) on day 0 and the other calves were maintained in contact with them.
doi:10.1371/journal.pone.0014621.t004
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rescued from clinical samples collected in the field. Furthermore, it
has been shown that the two rescued viruses which have been
examined (each derived from epithelium samples from animals
exhibiting clinical disease) were each highly pathogenic in cattle in
Denmark. The fidelity of the rescue system was further supported
by sequence analysis of RT-PCR derived amplicons correspond-
ing to the VP1 coding sequence obtained directly from the initial
clinical samples and also following virus rescue within cultured
cells. Just 1 nt difference was detected within 10,000 nt of
sequence information derived from samples tested before and
after virus rescue. In principle it is possible that some sequence
changes occurred elsewhere in the genome but clearly the rescued
viruses retained the ability to replicate within cells in culture and
also to cause disease in cattle. There seems no reason to believe
that this procedure for obtaining infectious FMDV should be any
less representative than standard virus isolation procedures.
Availability of the rescued viruses facilitates the characterization
of the circulating viruses including the identification of the
serotype by antigen ELISA and also the near complete genome
sequence determination. Furthermore, the rescued viruses are also
available for antigenic profiling (e.g. using a panel of monoclonal
antibodies) or virus neutralization assays to assess the efficacy of
current vaccine strains to combat them.
Both the FMDV Asia 1 strain from Afghanistan and the
serotype O strain (tentatively assigned as belonging to a new
PanAsia III sub-lineage) from Pakistan obtained through this virus
rescue procedure proved to be capable of initiating severe clinical
disease when inoculated into the tongues of calves kept within high
containment animal accommodation. Furthermore, the initial
infections rapidly spread to in-contact animals and classical
symptoms of FMD became apparent in each of the animals with
fever and multiple lesions in the mouth and on the feet. The profile
of viræmia (lasting 3–4 days) and the induction of an anti-FMDV
immune response detectable from 4–5 days post inoculation were
fairly typical (see [1]). It was apparent that a very high level of
viræmia (ca. 7–96109 genomes/ml of serum) was detected with
the serotype O virus in an in-contact animal which showed
particularly severe clinical signs of disease (and was therefore
euthanized at an early stage of the experiment). Due to the high
particle to pfu ratio (ca. 100) known for FMDV, and other
picornaviruses, it is likely this level of viræmia is roughly equivalent
to the high level (ca. 107.8 TCID50/ml) described for the serotype
C Noville strain of FMDV in cattle (see [1]).
A feature of the virus rescue system described here is that virus
amplification is achieved by infection of primary bovine cells
(BTY). This system can be expected to maintain the ‘‘field’’
Figure 5. Inoculation and infection of bovine calves by rescued FMDV (O/ISL/PAK/L1573/2009). Calves 2C1 and 2C5 were inoculated into
the tongue with the rescued virus (107 TCID50) and housed in contact with 4 control animals (in 2 separate pens containing calves 2C1-2C3 and 2C4-
2C6 respectively). The calves were monitored for clinical signs (including temperature (mean values for the animals in each group are shown, panel A)
and the presence of lesions in the mouth and on the feet). Note, on days 9 and 10 the inoculated calves were seen to be suffering from a secondary
bacterial infection which presumably accounted for the second temperature peak. Oral fluid was collected as swab samples and blood samples were
obtained and the serum was assayed for the presence of anti-O FMDV antibodies in a screening assay using a single dilution of serum (1:10) (panel B).
Positive samples (blocking .50%, which is the diagnostic cut off point and indicated by a horizontal line) were titrated (see Table 5). Note, calf 2C6
was euthanized at 4 dpi due to the severity of the clinical symptoms observed. The presence of FMDV RNA in serum samples was also determined by
real-time PCR and expressed as the number of RNA copies/ml serum (panel C) and the presence of FMDV RNA in mouth swab samples (mean of the
values determined for each group) is shown in panel D as in Figure 4.
doi:10.1371/journal.pone.0014621.g005
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characteristics of the viruses and not introduce specific adaptations
to cell culture within the capsid region which are frequently seen in
BHK cells for example. The initial introduction of the viral RNA
into BHK cells by electroporation was required due to the large
number of cells used for this process and is not expected to induce
adaptations, at least within the capsid region, since no capsid
functions were required to initiate the infection cycle within these
cells. The marked pathogenicity of the rescued viruses studied here
clearly shows that this characteristic of these viruses was not
significantly diminished in this procedure. There has been a recent
description [17] of a goat epithelial cell line which is highly
sensitive to FMDV and we have attempted to introduce FMDV
RNA directly into these cells but have been unsuccessful, the cells
either died or did not take up the RNA. However, it may well be
possible to replace the primary BTY cells by this goat cell line for
the propagation of the rescued virus.
Using RNA samples generated directly from clinical material
within our laboratory, it has been possible to rescue infectious
FMDV from samples containing quite low levels of viral RNA (Ct
value of 30). However, using RNA samples derived from clinical
samples collected in Pakistan and Afghanistan and then trans-
ported to Denmark, we have found that only samples containing a
much higher level of FMDV RNA (Ct value of about 20) have
been successfully rescued, this represents about a1000-fold higher
level of viral RNA. It should be noted that even a single break in
the RNA strand (ca. 8300 nt) is sufficient to destroy the infectivity
of the RNA whereas it will have rather little effect on the apparent
level of FMDV RNA detected in the real time RT-PCR assays as
these target small regions of the genome (ca. 100–150 nt).
Furthermore, the epithelium samples used here were transported
to regional laboratories before the RNA preservation was
performed. Direct placement of such samples into an RNA
preservative at the point of collection can be expected to improve
the efficiency of virus rescue. Clearly, if virus can be rescued from
swab samples collected directly into an RNA preservative then this
will be beneficial, on the basis of simplicity, and thus attempts to
achieve this are in progress.
When outbreaks of FMDV occur, it is important for national
authorities to be informed of the characteristics of the strain to
allow selection of appropriate vaccines. To obtain detailed
information about the properties of an outbreak strain, analysis
of the live virus is required. The identification of serotype can be
achieved by antigen ELISA if virus is available; however the
sensitivity of these assays is relatively low so the ability to grow the
virus can be important. Serotype identification can also be
achieved by sequencing of amplicons corresponding to the VP1
(1D) coding sequence. Such assays can be performed directly on
RNA obtained from clinical material but the analyses are greatly
facilitated by the ability to grow the virus and hence obtain RNA
preparations containing high levels of FMDV RNA. The pathway
of infections within an outbreak can be traced using full-length
genome sequence analysis [18,19]. This is much more readily
achievable with viruses that can be amplified in cell culture.
Finally, an assessment of the ability of antisera generated by
vaccines to neutralize outbreak strains is clearly desirable and this
also requires the availability of infectious virus. It is apparent that
this system to rescue FMDV from preserved RNA samples should
be a useful step forward in attempts to monitor FMDV circulation
within countries where the disease is endemic and hence aid
attempts to control it globally.
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